The purpose of the pharma package is to revise the current rules on medicines to make them more accessible to patients while ...

When executed with precision and transparency, ECAs can enhance trial efficiency, expand access and support evidence—while ...

National Institute of Neurological Disorders and Stroke (NINDS) trial of tissue plasminogen activator for acute ischaemic ...

The progress the UK has made as a global contributor to clinical trials is “remarkable”, says Lord James O’Shaughnessy, former health minister and author of the landmark report into the ...

A world-first clinical trial for a fridge-free vaccine has been launched in the UK which could greatly increase access to jabs in the future. The firm behind a vaccine that is completely stable at ...

A groundbreaking clinical trial has been initiated in the UK for a pioneering fridge-free vaccine, offering the potential to significantly broaden vaccination access. Stablepharma's tetanus ...

Stablepharma’s pioneering science has progressed into the clinical trial stage thanks to funding from shareholders and the UK Government, including Innovate UK and the NIHR. The first ...

Prof Faust said: “It is fantastic to see cutting-edge UK science reach the milestone of a first clinical trial and to be able to give the opportunity for people living on the south coast to take ...

The Medicines for Human Use (Clinical Trials) (Amendment) Regulations 2024 were officially signed into law on 10 April 2025, marking a significant development in the UK clinical trials framework ...

New regulations for running clinical trials in the UK have now been signed into law. A 12-month roll-out begins 11th April to deliver the most significant update to UK clinical trials regulation in ...

The U.K. is rolling out new regulations meant to reduce red tape for clinical studies and boost the nation’s role in international trials. The law, an update of the Medicines for Human Use ...